Mantle Cell Lymphoma (MCL) Recruiting Phase 2 Trials for Palbociclib (DB09073)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03478514Phase II Palbociclib +Ibrutinib in Mantle Cell LymphomaTreatment